A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS).
Naeemeh DiniAmin Pastaki KhoshbinRasoul AliannejadHooman BakhshandehKatayoun NajafizadehMahshid MehdizadehShahideh AminiPublished in: Trials (2024)
Iranian Registry of Clinical Trial (IRCT) IRCT20200415047080N3. Registered on 2022-07-12, 1401/04/21.
Keyphrases
- placebo controlled
- double blind
- phase iii
- phase ii
- clinical trial
- study protocol
- open label
- healthcare
- palliative care
- phase ii study
- acute myeloid leukemia
- quality improvement
- case report
- randomized controlled trial
- affordable care act
- hematopoietic stem cell
- pain management
- respiratory syncytial virus
- squamous cell carcinoma
- radiation therapy
- health insurance
- locally advanced